Funds And Strategies
  • Business
  • Stocks
  • World News
  • Investing
  • Business
  • Stocks
  • World News
  • Investing

Funds And Strategies

Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin June 4, 2025
June 4, 2025
RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

previous post
5 Biggest Blockchain ETFs in 2025
next post
Bird Flu Vaccine Stocks: 8 Companies Developing H5N1 Vaccines

Related Posts

Empire Metals Limited Announces Major Drilling Campaign Targeting...

June 3, 2025

Fintech Firm Velocity Raises US$10 Million for Enterprise...

May 29, 2025

How to Invest in Manganese Stocks

September 17, 2025

NorthStar Gaming to Host Q2 2025 Earnings Webinar...

August 8, 2025

What Was the Highest Price for Silver?

September 23, 2025

Accent Trial Data Demonstrates that Narmafotinib + Chemotherapy...

May 15, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (235)
    • Investing (1,174)
    • Stocks (206)
    • World News (648)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 fundsandstrategies.com | All Rights Reserved